Clinical trial
A Multicenter, Randomized, Prospective, Double-blind Study to Evaluate the Nephroprotective Effect of Delapril Alone or Combined With Manidipine in Patients With Type 2 Diabetes
NCT00157586 is registered in ClinicalTrials.gov with Mario Negri Institute for Pharmacological Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Prospective, Double-blind Study to Evaluate the Nephroprotective Effect of Delapril Alone or Combined With Manidipine in Patients With Type 2 Diabetes
- Lead sponsor
- Mario Negri Institute for Pharmacological Research
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2002
- Completion date
- June 30, 2008
- Enrollment
- 342
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes